Abstract
PURPOSE: The MOSAIC study: A multicenter, multinational, randomized, double-blind study to compare moxifloxacin oral tablets to standard oral antibiotic regimen given as first-line therapy in outpatients with acute infective exacerbations of chronic bronchitis. The MOSAIC study is unique and improved in its design. Specifically, it includes: established pre-exacerbation baseline; multicomparator, randomized, double-blind study; and short- and long-term follow-up. MOSAIC has been submitted to CHEST for publication and is currently under review.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
